BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Treatment
14 results:

  • 1. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
    Yue F; Zeng X; Wang Y; Fang Y; Yue M; Zhao X; Zhu R; Zeng Q; Wei J; Chen T
    BMC Microbiol; 2024 Jan; 24(1):8. PubMed ID: 38172689
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Aspirin inhibits prostaglandins to prevents colon tumor formation via down-regulating Wnt production.
    Feng Y; Tao L; Wang G; Li Z; Yang M; He W; Zhong X; Zhang Y; Yang J; Cheung S; McDonald F; Chen L
    Eur J Pharmacol; 2021 Sep; 906():174173. PubMed ID: 34033814
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Discrepancy between post-treatment infarct volume and 90-day outcome in the ESCAPE randomized controlled trial.
    Ganesh A; Menon BK; Assis ZA; Demchuk AM; Al-Ajlan FS; Al-Mekhlafi MA; Rempel JL; Shuaib A; Baxter BW; Devlin T; Thornton J; Williams D; Poppe AY; Roy D; Krings T; Casaubon LK; Kashani N; Hill MD; Goyal M
    Int J Stroke; 2021 Jul; 16(5):593-601. PubMed ID: 32515694
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
    Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
    Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure.
    Xie G; Wang X; Jiang R; Zhao A; Yan J; Zheng X; Huang F; Liu X; Panee J; Rajani C; Yao C; Yu H; Jia W; Sun B; Liu P; Jia W
    EBioMedicine; 2018 Nov; 37():294-306. PubMed ID: 30344125
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. brain metastases from colorectal cancer: characteristics and management.
    Mege D; Sans A; Ouaissi M; Iannelli A; Sielezneff I
    ANZ J Surg; 2018 Mar; 88(3):140-145. PubMed ID: 28687024
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair Deficiencies.
    Zhang Y; Fox JT; Park YU; Elliott G; Rai G; Cai M; Sakamuru S; Huang R; Xia M; Lee K; Jeon MH; Mathew BP; Park HD; Edelmann W; Park CY; Hong SY; Maloney D; Myung K
    Cancer Res; 2016 Jul; 76(14):4183-91. PubMed ID: 27262172
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth.
    Schumacher Y; Aparicio T; Ourabah S; Baraille F; Martin A; Wind P; Dentin R; Postic C; Guilmeau S
    Oncogene; 2016 May; 35(20):2602-14. PubMed ID: 26300003
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gamma knife surgery for intracranial cavernous hemangioma.
    Kim MS; Pyo SY; Jeong YG; Lee SI; Jung YT; Sim JH
    J Neurosurg; 2005 Jan; 102 Suppl():102-6. PubMed ID: 15662789
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
    Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
    Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study.
    Hildebrand J; De Witte O; Sahmoud T
    J Neurooncol; 1998 Apr; 37(2):155-60. PubMed ID: 9524094
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Chemotherapy of small cell bronchial cancers. Prognostic importance of complete response (1,280 patients). Groupe Petites Cellules].
    Lebeau B; Chastang C; Schuller MP; Thiberville L; Vaylet F; Derenne JP; Caillaud D; Muir JF; Coëtmeur D; Lemarié E
    Presse Med; 1995 Jan; 24(4):217-21. PubMed ID: 7899367
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.